Dextrose Injection
Product Images NDC 0338-0204

This is a set of instructions for handling drug vials. It specifies the size of the vials (13mm or 20mm) and describes the three components: vial cover, closure, and drug vial. The instructions indicate that the vial cover should be removed and the stopper should be disinfected before use.*

The text seems to be describing the process of inspecting and opening a medication container. It instructs the reader to peel off a foil cover, inspect an adaptor for moisture, and discard it if any is found. The container is labeled as a Mini-Bag Plus Container and has a breakaway seal inside a port. The text also mentions a Drug Vil Adaptor.*

This is a set of instructions for handling a vial. It advises placing the vial upright and holding it firmly while pushing the adaptor down until the vial snaps in place. It is important not to twist the vial.*

This text provides instructions for reconstitution of a medical substance. It implies the use of a bag and a vial, which must be fully seated and dry. The text also outlines a step-by-step process to break the seal, and indicates to use the substance only after the breakaway seal is fully bent and a clear gap is visible.*

This set of instructions appears to be for preparing powdered drug vials. The first sentence indicates that there is a separate set of instructions for liquid drug vials. The following steps describe how to prepare the powdered drug vial by holding a bag with the vial down, squeezing a solution into the vial until it is half full, and then shaking the vial to suspend the drug in the solution.*

This text provides instructions for a medical procedure that involves mixing and administering a drug solution. The steps involve squeezing a bag to force air into the drug vial and draining the suspended drug from the vial. The process is repeated until the vial is empty and the solution is thoroughly mixed. The text emphasizes the importance of ensuring that the drug is completely dissolved and specifically warns against removing the drug vial.*

This is a not-available response. The text seems to be incomplete or unreadable.*

This is a description of LoT EXP, an injection solution that comes in a MINI-BAG PLUS container and is used with a 13mm VIAL. The solution contains 25 g of Dexrrose Hyonous in 50 mL of solution with a pH of 4.0 (ranging from 3.2 to 6.5) and an osmolality of 252 MOSMOIIL (ohto). The solution must not be used in series connections and should not be administered simultaneously with blood. The user is cautioned to follow the dosage as directed by a physician and to ensure that the solution is properly mixed before use. Full information on this product can be obtained via an insert. The manufacturer of this product is Baxter Healthcare Corporation, located in Deerfield, Illinois, USA.*

This is information about Lot EXP, an injection USP solution contained in a Mini-Bag Plus container, for use with a 20mm vial. The container holds 50 mL of solution which includes 25g of Dextrose. The solution should be administered intravenously as directed by a physician with caution against using it in series connections or simultaneously with blood. The solution should only be used once and the seal should be broken and mixed before use. The solution provided by Baxter Healthcare Corporation in Deerfield, IL, USA is only to be used under specific conditions and with caution. More information about the solution's additives and compatibility should be obtained using the insert included in the package.*

This is a description for a medical product called LoT EXP. It is an injection containing 5% Dextrose, designed to be used with 13mm VIAL. This is a sterile and non-pyrogenic solution with an Osmolality of 252 mOsmol/L. The package insert provides full information, while the cautionary message includes not using in series connections, not administering simultaneously with 8L00D, and not using unless the solution is clear. The manufacturer of this product is Baxter Healthcare Corporation, based in Deerfield, Illinois, USA. The instruction from the manufacturer is to break the seal and mix before use.*

This is a product description for LoT EXP 2B0041LF, a 5% dextrose injection in a MINI-BAG PLUS container for use with 20mm vials. The solution is hyorous USP pH 4.0 with an osmolality of 252 mOsmol/L (cALc), and must be administered intravenously as directed by a physician. Caution must be taken to not use in series connections or administer simultaneously with blood, and the solution must not be used unless it is clear. The container is made in the USA by Baxter Healthcare Corporation and is for single dose use only. Before use, the container must be mixed after breaking the seal. More information can be found in the package insert.*